Bliss GVS Pharma Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bliss GVS Pharma Limited has announced the results of a postal ballot conducted between April 10, 2026 and May 9, 2026. Two special resolutions were passed with overwhelming shareholder approval. The first resolution appoints Mr. Vijayanarayanan Mahadevan as a Non-Executive Independent Director for five years, with 99.72% votes in favour (51.84 million votes). The second resolution appoints Mr. Deepak Rameshchandra Shah as a Non-Executive Independent Director for five years, also with 99.72% votes in favour. Total voter turnout was 49.14% of outstanding shares (51.99 million out of 105.79 million shares). Promoter group voted 100% in favour for both resolutions, while public institutions showed 94.10% support.
Both independent director appointments have been approved with strong shareholder backing. This strengthens the board's independent oversight and governance structure. The overwhelmingly positive voting outcome is positive for corporate governance and should be viewed favourably by investors.